Carregant...
Oncology approvals in 2020: a year of firsts in the midst of a pandemic
In 2020, despite challenges related to the COVID-19 pandemic, the US FDA approved 30 new drugs and biologic agents, 45 supplemental drug and biologic applications and 1 biosimilar application in oncology.
Guardat en:
| Publicat a: | Nat Rev Clin Oncol |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Nature Publishing Group UK
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7844812/ https://ncbi.nlm.nih.gov/pubmed/33514911 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41571-021-00477-1 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|